Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 3
1996 10
1997 4
1998 1
1999 2
2000 3
2001 6
2002 2
2004 6
2005 7
2006 19
2007 43
2008 58
2009 42
2010 30
2011 29
2012 24
2013 16
2014 18
2015 24
2016 35
2017 30
2018 26
2019 32
2020 68
2021 60
2022 62
2023 21

Text availability

Article attribute

Article type

Publication date

Search Results

578 results

Results by year

Filters applied: . Clear all
Page 1
NAFLD: a multisystem disease.
Byrne CD, Targher G. Byrne CD, et al. Among authors: targher g. J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012. J Hepatol. 2015. PMID: 25920090 Free article. Review.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Among authors: targher g. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 No abstract available.
Psoriasis and the metabolic syndrome.
Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G. Gisondi P, et al. Among authors: targher g. Clin Dermatol. 2018 Jan-Feb;36(1):21-28. doi: 10.1016/j.clindermatol.2017.09.005. Epub 2017 Sep 8. Clin Dermatol. 2018. PMID: 29241748 Review.
MAFLD and risk of CKD.
Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, Targher G, Byrne CD, Yuan WJ, Zheng MH. Sun DQ, et al. Among authors: targher g. Metabolism. 2021 Feb;115:154433. doi: 10.1016/j.metabol.2020.154433. Epub 2020 Nov 16. Metabolism. 2021. PMID: 33212070
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review.
Mantovani A, Byrne CD, Targher G. Mantovani A, et al. Among authors: targher g. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):367-378. doi: 10.1016/S2468-1253(21)00261-2. Epub 2022 Jan 12. Lancet Gastroenterol Hepatol. 2022. PMID: 35030323 Review.
578 results